CJC 1295 no dac + Ipamorelin 5mg/5mg

CJC 1295 (without DAC) and Ipamorelin 5mg/5mg lyophilized peptide blend for in vitro research. This dual-peptide formulation combines a modified GHRH analog (CJC 1295) with a selective growth hormone secretagogue receptor (GHS-R) agonist (Ipamorelin) for studying complementary receptor binding mechanisms and downstream cAMP/PKA signaling pathways in cell-based assays. For in vitro research use only. Not for human or veterinary use. Specifications: - Quantity: 5mg CJC 1295 No DAC / 5mg Ipamorelin - Form: Lyophilized Powder - Purity: >99% (HPLC Verified) Intended Use: Strictly for in vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All sales are final. Buyer assumes full responsibility for safe handling and regulatory compliance.